Business / Finance

RSS

USM to acquire Central Kentucky Mobility

United Seating & Mobility (USM) is excited to announce today that it has finalized a transaction with Central Kentucky Mobility (CKM) to acquire and merge its complex mobility business with USM. USM/CKM will continue services for Lexington, Louisville, as well as central, eastern and southern Kentucky.

25 Jul 2011

NBTY extends registered exchange offer for outstanding 9% Senior Notes due 2018

NBTY, Inc. announced today that it has extended the expiration date of its previously announced registered exchange offer for its outstanding 9% Senior Notes due 2018. NBTY originally issued the Private Notes, in an aggregate principal amount of $650.0 million, on October 1, 2010, in a private placement exempt from the registration requirements of the Securities Act of 1933, as amended.

22 Jul 2011

Modern Plastics moves to Shelton, Connecticut

Modern Plastics, one of the largest distributors of high-performance and engineering-grade stock shapes and medical-grade plastics, has moved from its former home in Bridgeport to Shelton, Connecticut. The new address is 88 Long Hill Cross Road, Shelton, Connecticut 06484 USA.

22 Jul 2011

SG Austria acquisition benefits Nuvilex with $1.5M in grant funding

Nuvilex, Inc. announced today that as part of its acquisition of SG Austria, Nuvilex will benefit from grant funding previously awarded to SG Austria for its live-cell encapsulation activities and other projects. The total grant funding awarded to SG Austria is approximately $1.5 million.

22 Jul 2011

Health care company settles class action lawsuit after Katrina deaths

A New Orleans judge gave preliminary approval today to a settlement agreement that would end a class-action lawsuit against one of the nation's largest publicly owned health care companies.

22 Jul 2011

Centric Health enters agreement to acquire majority stake in Performance Medical Group

Centric Health Corporation, Canada's leading diversified healthcare company, today announced that it has entered into an agreement to acquire 75% of the issued and outstanding securities of Performance Orthotics Inc., Footcare Dispensary Inc., and Foot Stress Inc..

22 Jul 2011

IDEXX Laboratories second quarter revenues increase 13% to $317.9 million

IDEXX Laboratories, Inc., today reported that revenues for the second quarter of 2011 increased 13% to $317.9 million, from $281.5 million for the second quarter of 2010. Organic revenue growth, as defined below, was 8%.

22 Jul 2011

GE second-quarter revenues decrease 4% to $35.6 billion

GE announced today strong second-quarter 2011 operating earnings from continuing operations of $3.7 billion, up 18%, or $0.34 per share, up 17%, from the second quarter of 2010.

22 Jul 2011

Global peripheral vascular devices market to reach $5.3B by 2017

The global peripheral vascular devices market is forecast to increase from $4.3 billion in 2010 to $5.3 billion by 2017, according to a new report available on companiesandmarkets.com.

22 Jul 2011

Aerocrine net sales decrease 1% to SEK 41.8m for January - June, 2011

Aerocrine secured the company's largest single order to date, valued at SEK 5.5 million.

From PHC Europe B.V. 22 Jul 2011

Bristol-Myers Squibb signs definitive agreement to acquire Amira Pharmaceuticals

Bristol-Myers Squibb Company and Amira Pharmaceuticals, Inc., announced today that the companies have signed a definitive agreement under which Bristol-Myers Squibb will acquire privately held Amira Pharmaceuticals, a small-molecule pharmaceutical company focused on the discovery and early development of new drugs to treat inflammatory and fibrotic diseases.

22 Jul 2011

Sirtex reports 4Q sales growth of 23%

Sirtex Medical Limited (ASX:SRX) today said sales of SIR-Spheres® microspheres, it’s targeted radioactive treatment for inoperable liver cancer, grew 23% in the fourth quarter of the 2011 Financial Year compared with the same quarter last year. Full year dose sales grew 19.3% compared to a 14% growth the year before.

21 Jul 2011

Australian anti-cancer company completes $2.6 million placement

Australian monoclonal antibody company, Immune System Therapeutics Limited (IST), today said it completed a private placement to raise $2 million from new and existing private and institutional investors in Australia. Investors have agreed to purchase 5,200,000 shares in the company at a price of $0.50 cents per share resulting in gross proceeds of $2.6 million.

21 Jul 2011

Neovasc to fund Tiara project with $4 million private placement

Neovasc Inc. today announced that it intends to complete a non-brokered private placement with accredited investors of up to four million equity units at the price of $1.00 per unit for aggregate gross proceeds of up to $4.0 million. The company expects that insiders will purchase approximately half of the units.

21 Jul 2011

Schiff Nutrition's fiscal 2011 net sales increase to $213.6 million

Schiff Nutrition International, Inc., announced results for the fiscal 2011 fourth quarter and year ended May 31, 2011.

21 Jul 2011

Nightingale fiscal 2011 revenue increases 5% to $17.4 million

Nightingale Informatix Corporation, an application service provider (ASP) of electronic medical record (EMR) software and related services, announces its financial results for the quarter and year ended March 31, 2011. All results are reported in Canadian dollars unless otherwise stated.

21 Jul 2011

Identification of third microRNA target triggers milestone payment from GSK to Regulus

Regulus Therapeutics Inc., a biopharmaceutical company leading the discovery and development of innovative medicines targeting microRNAs, today announced that it has identified a third microRNA target in its alliance with GlaxoSmithKline (GSK), triggering a preclinical milestone payment from GSK.

21 Jul 2011